BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,711.90
- Market cap
- ₹4,227 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 43.2×Sector 45.9×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
Novartis India Management Change
Evonile Pharma (formerly Novartis India) appointed Mr. Gagan Sharma as President – Specialty Business and Senior Management Personnel effective October 26, 2026. The filing is a Regulation 30 senior management appointment intimation.
Novartis India Other Announcement
Novartis India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine periodic disclosure.
Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India Fund Raise of ₹900 Cr
Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.
- Value
- ₹900.0 Cr
Novartis India Credit Rating
Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.
Other capital structure change announcements
All →Ola Electric Mobility Capital Structure Change
Ola Electric allotted 37,02,72,665 partly paid-up rights shares at Rs 16.20 each, about Rs 599.84 Crore on application. Balance call money remains payable.
- Value
- ₹599.8 Cr
Mihika Industries Capital Structure Change
Mihika Industries fixed terms for a ₹90 crore partly paid rights issue. Record date is November 6, 2026, at 9 rights shares per share held.
- Value
- ₹90.00 Cr
Swelect Energy Systems Capital Structure Change
SWELECT approved up to Rs 4.36 crore equity infusion into its wholly owned subsidiary. The funds will develop a 4.5 MWp group captive solar plant in Kerala.
- Value
- ₹4.36 Cr
- Execution
- Multiple tranches per the investee company's offer letter
- solar capacity (DC)
- 4.5 MW
Jindal Capital Capital Structure Change
Jindal Capital's board approved rights issue terms for up to Rs 16.22 Crore. The issue opens 17 November 2026 and closes 1 December 2026.
- Value
- ₹16.22 Cr
- Execution
- Issue opens 17 November 2026, closes 1 December 2026
Atul Capital Structure Change
Atul Ltd submitted its daily buy-back report for 2 November 2026, with 4,500 shares bought back at an average price of Rs.5,072.37. Cumulative buy-back spend reached Rs.87.72 Crore of the Rs.90 Crore earmarked.
- Value
- ₹2.28 Cr
Transport Corporation of India Capital Structure Change
Transport Corporation of India extinguished 1,562,500 bought-back equity shares, completing its buyback at Rs 960 per share. The buyback totals about Rs 150 Crore.
- Value
- ₹150.0 Cr